000 01365 a2200385 4500
005 20250513111852.0
264 0 _c19970317
008 199703s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aNaisbitt, D J
245 0 0 _aDisposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cFeb 1997
300 _a884-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmodiaquine
_xanalogs & derivatives
650 0 4 _aAntimalarials
_xblood
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Design
650 0 4 _aGlutathione
_xblood
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aMolecular Structure
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTetradecanoylphorbol Acetate
_xpharmacology
650 0 4 _aTritium
700 1 _aRuscoe, J E
700 1 _aWilliams, D
700 1 _aO'Neill, P M
700 1 _aPirmohamed, M
700 1 _aPark, B K
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 280
_gno. 2
_gp. 884-93
999 _c9013288
_d9013288